JDRF is now Breakthrough T1D. As the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition. For more information, visit www.BreakthroughT1D.org
We're tracking Breakthrough T1D's market expansion
How Breakthrough T1D's international expansion compares to its competitors
Breakthrough T1DYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Breakthrough T1DYou | 0 | 0 | — | 0 | 0 |
Development Coordinator
View postingPortland, OR · 2w ago
Operations Assistant
View postingOmaha, NE · last mo.
Operations Assistant
View postingWellesley, MA · last mo.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Continuity Biosciences and Breakthrough T1D partner to advance NICHE cell-therapy platform for type 1 diabetes, aiming for first-in-human clinical study.
Continuity Biosciences and Breakthrough T1D announce strategic collaboration to develop NICHE® cell therapy platform for type 1 diabetes, supporting IND filing and phase 1/2a clinical trial planning.
Continuity Biosciences and Breakthrough T1D partner to advance NICHE cell therapy platform for type 1 diabetes to first-in-human clinical trials, combining expertise in drug delivery and diabetes innovation.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Breakthrough T1D's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
